Cases of Pulmonary Hypertension on the Rise
The number of new patients suffering from pulmonary hypertension has been rising fast in the last few years as indicated by the surge in new cases, a report from UK’s the Health and Social Care Information Centre (HSCIC) reveals.
Pulmonary hypertension is an ailment that develops when the pulmonary arteries located in the heart become tight or narrow leading to constricted passages. The progressive disease comes with symptoms such as fatigue, breathlessness, angina, and weakness.
In the latest report published by HSCIC, a UK centre for information on social care and health, there is a worrying trend with more and more people falling victim to the disease. Observations based on the last five years indicate that the heart condition has increased by 21% or by a fifth.
There is no clear information on what causes the disease and this makes it more complicated to find a cure that can help people deal with the issue. At the moment there is no treatment for pulmonary hypertension and the only option is dealing with the symptoms. It is estimated that less that 40% of the victims live more than five years after being diagnosed with the progressive disease.
Data from an audit done in the UK shows that by the end of 2010, there were 1,789 pulmonary hypertension referrals. This figure jumped to 2,151 by the end of 2015 representing a jump of 21% and the same trend is also being witnessed in other regions outside the UK.
Simon Gibbs, the lead clinician during the audit states that though the disease is rare, the recent findings have many people concerned because if the referrals continue to rise the disease will no longer be so rare.
A look at the statistics indicates that the number of victims who went for treatment in the eight specialist centres for hypertension in 2015 soared by 56% hitting the 6,671 mark while in 2010 the number was 4,287.
To address the rising cases, pulmonary hypertension centres and specialists are forced to work extra hard so as to deal with the situation and also increase awareness and educate the public about the ailment and ways of managing it.
The report also focused on the “Five-year survival” which showed that the median period varies between 2 years 13 days and 4 years 213 days and is influenced by the type /nature of the heart condition which include heritable, connective tissue, idiopathic, and anorexigen
The longest median survival rate was 4 years and 213 days for the left heart disease followed by 4years 104 days and applied to anorexigen, heritable, or idiopathic induced hypertension, while for connective tissue condition was 3 years and 335 days and lastly came lung disease with 2 years and 13 days.